French recommendations on control measures to reduce the infectious risk in immunocompromised patients
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | French recommendations on control measures to reduce the infectious risk in immunocompromised patients |
| Type de publication | Journal Article |
| Year of Publication | 2017 |
| Auteurs | Zahar J.-R, Jolivet S., Adam H., Dananche C., Lizon J., Alfandari S., Boulestreau H., Baghdadi N., Bay J.-O, Beneteau A.-M, Bougnoux M.-E, Brenier-Pinchart M.-P, Dalle J.-H, Fournier S., Fuzibet J.-G, Kauffmann-Lacroix C., Le Guinche I., Lepelletier D., Loukili N., Lory A., Morvan M., Oumedaly R., Ribaud P., Rohrlich P., Vanhems P., Aho S., Vanjak D., Gangneux J.-P |
| Journal | JOURNAL DE MYCOLOGIE MEDICALE |
| Volume | 27 |
| Pagination | 449-456 |
| Date Published | DEC |
| Type of Article | Review |
| ISSN | 1156-5233 |
| Mots-clés | ENVIRONMENT, Immunocompromised host, Neutropenia, Prevention |
| Résumé | The increase use of immunosuppressive treatments in patients with solid cancer and/or inflammatory diseases requires revisiting our practices for the prevention of infectious risk in the care setting. A review of the literature by a multidisciplinary working group at the beginning of 2014 wished to answer the following 4 questions to improve healthcare immunocompromised patients: (I) How can we define immunocompromised patients with high, intermediate and low infectious risk, (II) which air treatment should be recommended for this specific population? (III) What additional precautions should be recommended for immunocompromised patients at risk for infection? (IV) Which global environmental control should be recommended? Based on data from the literature and using the GRADE method, we propose 15 recommendations that could help to reduce the risk of infection in these exposed populations. (C) 2017 Elsevier Masson SAS. All rights reserved. |
| DOI | 10.1016/j.mycmed.2017.10.004 |